Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Genfit's share price for the quarter that ended in Dec. 2023 was $3.45. Genfit's Shares Outstanding (EOP) for the quarter that ended in Dec. 2023 was 49.84 Mil. Therefore, Genfit's market cap for the quarter that ended in Dec. 2023 was $171.93 Mil.
Genfit's quarterly market cap
stayed the same
from Jun. 2023 ($189.37 Mil) to Sep. 2023 ($189.37 Mil) but then
declined
from Sep. 2023 ($189.37 Mil) to Dec. 2023 ($171.93 Mil).
Genfit's annual market cap
declined
from Dec. 2021 ($249.08 Mil) to Dec. 2022 ($183.90 Mil) and
declined
from Dec. 2022 ($183.90 Mil) to Dec. 2023 ($171.93 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Genfit's Enterprise Value for Today is $215.21 Mil.
Genfit Market Cap Historical Data
The historical data trend for Genfit's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, Genfit's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Genfit's Market Cap Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Genfit's Market Cap distribution charts can be found below:
* The bar in red indicates where Genfit's Market Cap falls into.
Genfit Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Genfit's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Genfit (OTCPK:GNFTF) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Genfit Market Cap Related Terms
Thank you for viewing the detailed overview of Genfit's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. The company conducts clinical trials in a variety of European and North American countries when advancing through stages of development. It has one segment the research and development of innovative medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
GNFTF has been successfully added to your 